5Liaw YF, Chu CM. Hepatitis B virus infection [ J]. Lancet,2009,373 (9663) :582-592.
6Liaw YF, Leung N, Kao JH, et al. Asian-Pacific consensus statement on the management of chronic hepatitis B : a 2008 update [ J ]. Hepatol Int, 2008,2(3 ) :263-283.
7Beutels P, Musabaev EI, Van Damme P, et al. The disease burden of hepatitis B in Uzbekistan[ J]. J Infect,2000,40(3) :234-241.
8Striz I, Brabcova E, Kolesar L. Cytokine networking of innate immunity cells:a potential target of therapy [ J ]. Clin Sci, 2014, 126 ( 9 ) : 593-612.
9Li WY, Jiang YF, Jin QL, et al. Immunologic characterization of posthepatitis cirrhosis caused by HBV and HCV infection[ J ]. J Biomed Biotechno1,2010. DOI : 10.1155/2010/138237.
10Del Bas JM, Ricketts ML, Vaqu M, et al. Dietary procyanidins enhance transcriptional activity of bile acid-activated FXR in vitro and reduce triglyceridemia in vivo in a FXR-dependent manner[ J]. Mol Nutr Food Res,2009,5 (3) :805-814.
